Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUSTO: Ultra-short Glucocorticoids and Tocilizumab for Giant Cell Arteritis
NCT03745586Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Dec 2018
- Primary completion
- Nov 2020
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in giant cell arteritis (GCA), sponsored by Insel Gruppe. Started Dec 2018; status: completed.
02
Drugs
tocilizumab
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on NCT03745586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03745586.